Sansure Biotech Inc (688289) — Free Cash Flow Generation Index
Sansure Biotech Inc (688289) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-3.36 Million represents 0% of operating cash flow (CN¥59.72 Million). See how liquid is Sansure Biotech Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Sansure Biotech Inc across 8 annual periods. Explore debt repayment capacity of Sansure Biotech Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sansure Biotech Inc (2018–2025)
Year-by-year Free Cash Flow Generation Index for Sansure Biotech Inc. For the full company profile including market capitalisation, see market cap of Sansure Biotech Inc.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | CN¥-185.81 Million | CN¥183.96 Million | CN¥369.77 Million | ▼ -89.0% |
| 2024 | -0.53x | CN¥-146.66 Million | CN¥274.45 Million | CN¥421.10 Million | ▲ +82.7% |
| 2023 | -3.08x | CN¥-347.81 Million | CN¥112.82 Million | CN¥391.35 Million | ▼ -494.4% |
| 2022 | 0.78x | CN¥2.00 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -2.5% |
| 2021 | 0.80x | CN¥1.50 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▼ -16.4% |
| 2020 | 0.96x | CN¥2.53 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▲ +283.1% |
| 2019 | -0.52x | CN¥-11.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +76.9% |
| 2018 | -2.27x | CN¥-22.84 Million | CN¥10.07 Million | CN¥32.90 Million | — |